Reducing the frequency of eye screening in patients with diabetes from annually to every other year would delay detection of sight-threatening diabetic retinopathy (STDR) and proliferative diabetic ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

Please provide your email address to receive an email when new articles are posted on . The use of artificial intelligence in screening for diabetic retinopathy led to accurate referrals in Rwanda ...

Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based diabetic ...

Recent reports suggest diabetic retinopathy is more common in younger people than previously thought, leading to a call for more frequent screening for this condition and more attention to follow-up ...

Some hospitals are finding it difficult to scale AI across their enterprise — with this process often complicated by things like inadequate technology infrastructures, varying needs across specialties ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. This piece also marks part ...

While artificial intelligence (AI)-assisted detection of diabetic retinopathy has the potential to expand access to screening, few patients with diabetes have been evaluated with the technology since ...

The preparation of evidence-based guidelines is highlighted by the WHO as an important component in the concerted effort to eliminate avoidable blindness. [149] This review has highlighted ...

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease. Concerningly, DRD is the leading cause of preventable ...